TPST Tempest Therapeutics, Inc.
Price Chart
Executive Summary
Director Ms. Simantov resigned from the board of Tempest Therapeutics effective May 23, 2026, with no disagreement disclosed. She entered a separation agreement waiving accrued retainer fees but retaining stock options and indemnification rights. This is a routine board departure with no material financial impact.
Actionable Insight
Routine board departure with no red flags. No trading action warranted; monitor for any future director departures that could signal governance instability.
Key Facts
- Ms. Simantov resigned from the Board of Directors effective May 23, 2026
- Resignation was not due to any disagreement with the company's operations, policies, or practices
- Separation Agreement waives all accrued and unpaid retainer fees
- Outstanding stock option awards and share ownership are unaffected
- Indemnification agreement remains in force for six years from separation
Financial Impact
No material financial impact; waived retainer fees are immaterial for a $26M market cap company
Risk Factors
- Further board departures could signal governance concerns
- Small biotech with $26M market cap faces inherent cash runway risk
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-248648 |
| Document: 0001193125-26-248648-index-headers.html | 0001193125-26-248648 |
| Document: 0001193125-26-248648-index.html | 0001193125-26-248648 |
| Document: 0001193125-26-248648.txt | 0001193125-26-248648 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 29, 2026
14d ago
|
8-K
| $1.45 $1.27 | ▼ −12.41% | ▼ −9.66% | $1.26 (−13.10%) |
|
May 29, 2026
15d ago
|
Press Release
| $1.53 $1.27 | ▲ +16.99% | ▲ +16.70% | $1.26 (+17.65%) |
|
May 22, 2026
21d ago
|
8-K
| $1.77 $1.31 | ▲ +25.99% | ▲ +27.20% | $1.26 (+28.81%) |
|
May 22, 2026
21d ago
|
8-K
| $1.77 $1.31 | ▲ +25.99% | ▲ +27.20% | $1.26 (+28.81%) |
|
May 14, 2026
29d ago
|
8-K
| $1.83 $1.86 | ▼ −1.64% | ▼ −0.68% | $1.26 (+31.15%) |
|
Apr 29, 2026
6w ago
|
Press Release
| $1.74 $2.15 | ▲ +23.56% | ▲ +20.45% | $1.26 (−27.59%) |
|
Apr 6, 2026
9w ago
|
EFFECT
| $1.59 $2.14 | ▲ +34.59% | ▲ +30.46% | $1.26 (−20.75%) |
|
Apr 2, 2026
10w ago
|
S-3
| $1.59 $2.05 | ▲ +28.93% | ▲ +25.31% | $1.26 (−20.75%) |
|
Mar 30, 2026
10w ago
|
Press Release
| $1.52 $1.56 | ▲ +2.63% | ▼ −1.67% | $1.26 (−17.11%) |
|
Mar 11, 2026
13w ago
|
Press Release
| $2.40 $2.16 | ▼ −10.00% | ▼ −7.81% | $1.26 (−47.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access